Tag: LIVE

Happy New Year from Blue Horseshoe Stocks

With tomorrow’s holiday splitting another week right down the middle, we’d like to take this opportunity to wish our audience a very safe, healthy and Happy New Year. 2013 was an extremely successful year for us, and we are really excited to make 2014 even better!

At this point all of our regular readers are aware of our ongoing interest in marijuana -related stocks. We’ve covered this relatively new and rapidly growing industry tenaciously over the past year-and-a-half, and to our great pleasure, it has provided us with countless opportunities to profit.

Cannabis Science, Inc. CBIS

CBIS is an old favorite of ours that has delivered the goods on several occasions. Most recently, following our latest report which included the stock (12/19), CBIS touched its 52-wk low at .028, and has been really heating up since that time, reaching a high of .04 yesterday, good for a rebound of 43%

The stock closed at the high-of-day on more than 5.5x its 3mo. average volume, which certainly qualifies CBIS as a potential momentum play.

Here are some of the other stocks we’ve been  continuously tracking in the cannabis industry:

Hemp, Inc. HEMP,

Medical Marijuana, Inc. MJNA

Growlife, Inc. PHOT

Also consider: FITX, GRNH, SKTO, TRTC (Click here to view a past report containing much larger list of marijuana-related stocks)

We want to have the sector as a whole on watch as these plays are heating up, and seem poised to begin the New Year on a strong note. That fact, in concert with all of the recent progress that marijuana has made on both legislative and social levels, has us thinking that 2014 could be a landmark year for marijuana related stocks.

We also prepared a video chart presentation on the subject:

Progress Watch Corp. PROW

We first alerted on PROW back on Dec. 20th, at which time the stock saw a low of .0065, and we subsequently followed it to a high of .013. (+100%) After pulling back to .008 the following day, the stock has now surged back to re-test that .013 mark, giving us chances at up to an additional 65% gain.

PROW is likely to remain on our radar and in our reports well into the New Year.

Kandi Technologies Group, Inc. KNDI

KNDI came off of yesterday’s morning report to have a solid session, so we wanted to congratulate anyone who was able to take advantage. The stock saw a daily low of 11.50, followed by the high at 12.79, marking an intraday gain of just over 11%  A pretty good move for a stock in that price range, and a nice addition to the significant gains we’ve already seen from KNDI.

Extended Watchlist:
DROP, ONVO, CYTR, IMMU, LIVE, DRYS, FREE, GNK, MDNT(Readers pick, coming off recent 52week lows, thanks to John)

BGMD, CYTR, ECTE, NRF, SIOCF & Extended Watchlist

BG Medicine, Inc. BGMD

BGMD helped us toward an extremely successful day of trading on Tuesday, and for the second day in a row, the number one spot of all newsletters on the Penny Stock Rumble.

After briefly touching a low of .6115, the stock exploded to a subsequent high of 1.29, marking a possible gain of up to 111% for sharp traders. This happened on more than 33x the 3mo. average volume, qualifying BGMD for momentum-mover status.

We’ll definitely want to follow the activity on this play today, it appears to want to gap up this morning, and could still have added gains in store for us.

Big Volume News Plays

The following three picks come off of our pre-market scanner with news out today, and we wanted to radar them. As we’ve shown with the past couple of days, our scans routinely reveal hidden gems that can provide us with an edge. We’ve taken the Penny Stock Rumble two days in a row, now let’s see that hat-trick!

CytRx Corp. CYTR
Reporting Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial  >>>FULL PR

Echo Therapeutics, Inc. ECTE
Echo to receive a $10 million cash investment from MTIA and Platinum Partners –Company will withdraw the offering identified in recent Form S-1 filing>>>FULL PR

Northstar Reality Finance Corp. NRF
NorthStar Realty Finance announces plan to spin-off Asset Management Business into a separate publicly traded company in a tax-free transaction >>>FULL PR

Sierra Iron Ore Corp. SIOCF

While we have not been paid on SIOCF, we are aware of a paid promotion currently underway on the stock, so we thought we’d share that info.

Aside from that, the stock shows a chart that is looking ripe for a possible move. The accumulation/distribution has reached all-time highs, the RSI is coming off of being oversold, and is pushing through the 50-line. The MACD has also undergone a bullish cross.

Extended Watchlist:
GRPN, LIVE, OREX, ARIA, FREE,

PLUG, IACH, CALI, AAPL & Extended Watchlist

Plug Power, Inc. PLUG

PLUG turned in a solid session yesterday, as anticipated, following its appearance in our morning report. Initially, the stock opened at 1.04, made a 12.5% move to 1.1699, and would settle back to the 1.04 level before running up to a daily high of 1.28 for an added 23% intraday gain opportunity.

Following a strong close just a tick below the high-of-day (1.27) we’re going to be following this play once again, as the momentum could easily carry it even higher. As you can see on the chart below the next key area of resistance to watch for a break comes at the 1.45 level. We’ll need to see the stock hold support above a dollar, or it could pull back to fill the gap on the chart back to the .80-range.

Information Architects Corp. IACH

We’ve been tracking IACH via our Extended Watchlist for most of the week. The stock recently made a huge 1800% move from .001-.019, prompting us to put it on our radar,  monitoring for pullbacks and subsequent bounce opportunities, and it delivered just that.

After dipping back to .008, we saw a rebound back to .013, and a strong close at .012. Gains of up to 63% could have been achieved on the bounce.

China Auto Logistics, Inc. CALI

We also want to keep an eye on CALI, which popped up on our pre-market scan as it is gapping up heavily on the heels of a morning press release.

TIANJIN, CHINA, Dec 05, 2013 (Marketwired via COMTEX) — China Auto Logistics Inc. (the “Company” or “CALI”) (NASDAQ: CALI), a top seller in China of luxury imported automobiles, and a leading provider of auto-related services, reported today that on November 30, 2013, its subsidiary, Tianjin Binhai Shisheng Trading Group Co., Ltd. (“Shisheng”) signed an equity transfer agreement with Hezhong International Development Co, Ltd. to acquire Tianjin Zhonghe Auto Sales Service Co., the owner and operator of the Airport International Automall in Tianjin (the “Automall”). The Company plans to develop the Automall into a key site for what it believes can become one of the largest used car businesses in China.

Apple, Inc. AAPL Options

With the way AAPL has been gaining a head of steam lately, it seems plausible to imagine the stock surpassing $600 as we head into the new year. As a result, we are putting the 01/18 $585 Calls on our radar which closed at 12.25 yesterday, meaning the break-even point is 597.50. What we’re looking for, is to see the stock push past to the $610-15 level in January, which could provide triple-digit gains for the 01/18 $585 Calls.

The company finally signed a deal with China Mobile to get its iPhones on their network, as reported by the The Wall Street Journal this morning. China Mobile is comprised of over 700 million users, which obviously represents huge opportunity (in a market more than twice the population of the US) for Apple to boost foreign sales moving forward.

Extended Watchlist:
CBMX, DRYS, MTG, FREE, FCEL, EGLE, LIVE, OCZ

CLNO, CBMX, MJNA, HEMP & Extended Watchlist

Cleantech Transit, Inc. CLNO 

CLNO hit a high of .193 yesterday morning,  before we observed a lunchtime pullback to .10. On the intraday chart (below), the RSI started to look oversold, and the PPO crossed over, giving us an indication that it was a good time to consider re-entry. In a dip-and-rip scenario, we had a chance at up to 70% in intraday gains as the stock traveled back to the .17-range.

From our original alert at .0055, CLNO has risen as much as 3409%

CLNO is currently receiving a rare “100% Buy” Rating from BARCHART.COM

Recent News:

Las Vegas, NV, Jun 21, 2013 (WORLD STOCK WIRE via COMTEX) — CleanTech Transit, Inc. (OTCQB: CLNO) announced today that it has acquired 81% of the issued and outstanding shares of Discovery Carbon Environmental Securities Corporation (“Discovery”), a Nevada corporation. The acquisition advances the strategy of developing significant market share in the alternative clean energy sector. Discovery’s proprietary GreenTrees(TM) for renewable energy, and EvoCert(TM) environmental credits for offsetting business and individual carbon foot prints are some of the exciting products Discovery provides to clients throughout the world.

For More Info on CLNO Visit:

www.cleantechtransit.net

OPTIONS-TRADING NOTES:

Our interest in SPY Calls yesterday morning paid instant dividends regardless of which levels we chose. Take a look at the daily ranges on the following contracts:

$156 Calls – Low: 2.29 – High: 3.43  (Close: 3.00)

$156.50 Calls – Low: 2.00 – High: 3.03 (Close: 2.60)

$157 Calls – Low: 1.60 – High: 2.59 (Close: 2.13)

$157.50 Calls – Low: 1.35 – High: 2.20 (Close: 1.83)

$158 Calls: Low: 1.05 – High: 1.80 (Close: 1.48)

CombiMatrix Corp. CBMX

CBMX appeared on our extended watchlist for the second time yesterday since April 4th.

Back in April, we saw a move from 3.46-4.62 following our alert on the stock.

Yesterday, a similarly-sized spike took CBMX on a ride from 3.35 to 4.60 on the heels of an important announcement from the company regarding its approval by the New York State Board of Health to market its prenatal miscarriage analysis tests throughout the state. We refer you to the following:

IRVINE, Calif., June 25, 2013 (GLOBE NEWSWIRE) — CombiMatrix Corporation (CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer diagnostics, today announced that its chromosomal microarray analysis (CMA) test for miscarriage analysis has received conditional approval from the New York State‘s Department of Health for testing on patient samples from the state. >>>WHOLE RELEASE

Other Extended Watchlist Winners:

While we’re on the subject of good performers to come off of our extended watchlist, we must turn our attention to a couple of our favorite cannabis stocks, MJNA, and HEMP. Our coverage of hemp-related plays has tapered recently, as we’ve had many other pressing issues to discuss. But it seems that we re-introduced them at a good time yesterday.

HEMP was as low as .021 before hitting a high of .028, a move of 33%

MJNA traded from .131 on up to .1453. That was good for an intraday gain of 11%

Extended Watchlist:

EWRL, PGRX(Coming off of recent lows), RSOL, LIVE,

DRRX, PPHM & Extended Watchlist

Durect Corp. DRRX

We are putting DRRX on our radar this morning; it has recently come off of a bottom, and is gaining some momentum as it begins its recovery. Prior to May, this pharmaceutical play was trading at a base level well above 1.20, before seeing a large spike followed by a sharp dropoff. If DRRX can break through resistance at the 50DMA & 200DMA there’s a chance it could come up to fill that gap on the chart. A return to previous levels from here could yield gains of up to 20%

In addition to a connection with pharma giant Pfizer, the company has also gotten FDA acceptance of a New Drug Application (NDA) as outlined in yesterday’s PR:

CUPERTINO, Calif., June 20, 2013 /PRNewswire via COMTEX/ — DURECT Corporation (Nasdaq: DRRX) today announced that the New Drug Application (NDA) for the investigational product POSIDUR (SABER-Bupivacaine) has been accepted by the U.S. Food and Drug Administration (FDA) indicating that the application is sufficiently complete to permit a substantive review. POSIDUR is a post-operative pain relief depot that utilizes DURECT’s patented SABER technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery. DURECT submitted the NDA as a 505(b)(2) application. The Prescription Drug User Fee Act (PDUFA) goal date (the date the FDA expects to complete its review of the NDA) has been confirmed as February 12, 2014.

Peregrine Pharmaceuticals, Inc. PPHM

Speaking of pharmaceutical plays, one of the stocks that we continuously monitor is PPHM. Many of you will remember back in May when the stock provided us with some serious opportunities for profit.

Recently PPHM has been in a marked downtrend, and as you can see on the chart below, indicators seem to confirm this fact. We are going to want to put this one on bottom watch over the next several sessions, as the resulting bounce/s could be significant.

Side Note: 

Since Ben Bernanke’s recent comments regarding the Fed’s upcoming tapering of quantitative easing measures, markets have been in freefall. If no reversal occurs and that remains the overall trend, we are going to want to keep an eye on SPY Puts, VIX/VXX Calls.

Extended Watchlist:
ONCI, ONCO, LIVE, KERX, MSTX  

Get Our FREE Daily Reports!

SUBSCRIBE